Published in Blood Weekly, May 11th, 2006
Since joining Schering-Plough in 1982 as a financial analyst, Russo has held a number of positions within the company's finance, contracts and marketing organizations. Most recently, Russo was in charge of Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin) in the company's cholesterol joint venture in the U.S. and was instrumental in driving higher sales and market share of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.